← 返回

患者来源的肿瘤-免疫细胞相互作用模型

英文原题:Patient-derived models of tumor-immune cell interactions.

查看英文原题

Patient-derived models of tumor-immune cell interactions.

PubMed 2025/11/03(内容时间) Methods Cell Biol

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

新型治疗策略凸显了对更接近原发肿瘤生理和遗传特性的先进离体细胞培养模型的需求。患者来源的模型可作为研究癌细胞与其微环境之间相互作用以及测试潜在治疗靶点的有吸引力的策略,为精准肿瘤学铺平道路。在本章中,我们提供了详细的分步方案,以实现患者来源的结直肠癌(CRC)类器官与自体TIL(肿瘤浸润淋巴细胞)(TILs)的直接共培养系统。本方案提供了一种直接接触形成类器官的上皮细胞顶端侧的方法。该方法可用于研究患者特异性的细胞间相互作用、T 细胞功能和效力,并为验证潜在的免疫原性新抗原提供了稳健的平台。

展开英文摘要原文

Novel therapeutic approaches highlight the need for advanced ex vivo cell culture models that more closely resemble the physiological and genetic properties of the primary tumor. Patient-derived models could serve as an attractive strategy to investigate the crosstalk between cancer cells and its microenvironment and to test potential therapeutic targets, paving the way for precision oncology.

In this chapter, we provide a detailed step-by-step protocol for enabling a direct co-culture system of patient-derived colorectal cancer (CRC) organoids with autologous tumor-infiltrating lymphocytes (TILs). The present protocol provides a methodology to gain direct access to the apical side of the epithelial cells forming the organoids. This method can be used to investigate patient-specific cell-to-cell interactions, T cell functionality and efficacy and provides a robust platform to validate potential immunogenic neoantigens.

论文信息

作者
Nemati N、Boeck N、Trajanoski Z
第一作者单位
Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.Austria
通讯作者单位
Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: zlatko.trajanoski@i-med.ac.at.Austria
期刊
Methods in cell biology2026
原文标识
PubMed 41620277 · DOI 10.1016/bs.mcb.2025.10.001